• 1
    Yanagisawa, M., Kurihara, H., Kimura, S., et al (1988) A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411415.
  • 2
    Sakurai, T., Yanagisawa, M., Takuwa, Y., et al (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732735.
  • 3
    Hosoda, K., Nakao, K., Hiroshi-Arai, K., et al (1991) Cloning and expression of human endothelin-1 receptor cDNA. FEBS Lett. 287: 2326.
  • 4
    Yokomori, H., Oda, M., Ogi, M., et al (2001) Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver. Liver 21: 114122.
  • 5
    Ahmed, S. I., Thompson, J., Coulson, J. M., Woll, PJ. (2000) Studies on the expression of endothelin, its receptor subtypes, and converting enzymes in lung cancer and in human bronchial epithelium. Am J Respir Cell Mol Biol. 22: 422431.
  • 6
    Maeda, S., Miyauchi, T., Iemitsu, M., et al (2004) Endothelin receptor antagonist reverses decreased NO system in the kidney in vivo during exercise. Am J Physiol Endocrinol Metab. 286: E609E614.
  • 7
    Garrido Mdel R., Israel, A. (2004) Endothelin ETB receptor signaling in the median eminence and subfornical organ of the rat brain. Neuropeptides 38: 304310.
  • 8
    Nelson, J. B., Nabulsi, A. A., Vogelzang, N. J., et al (2003) Suppression of prostate cancer induced bone remodeling by the endothelin receptor A antagonist atrasentan. J Urol 169: 11431149.
  • 9
    Chou, Y. C., Perng, J. C., Juan, C. C., et al (1994) Endothelin-1 inhibits insulin-stimulated glucose uptake in isolated rat adipocytes. Biochem Biophys Res Commun. 202: 688693.
  • 10
    Lee, Y. C., Juan, C. C., Fang, V. S., et al (1998) Evidence that endothelin-1 (ET-1) inhibits insulin-stimulated glucose uptake in rat adipocytes mainly through ETA receptors. Metabolism 47: 14681471.
  • 11
    Shih, K. C., Kwok, C. F., Ho, LT. (2000) Combined use of insulin and endothelin-1 causes decrease of protein expression of beta-subunit of insulin receptor, insulin receptor substrate-1, and insulin-stimulated glucose uptake in rat adipocytes. J Cell Biochem. 78: 231240.
  • 12
    Roden, M., Vierhapper, H., Liener, K., Waldhausl, W. (1992) Endothelin-1-stimulated glucose production in vitro in the isolated perfused rat liver. Metabolism 41: 290295.
  • 13
    Tran-Thi, T. A., Kawada, N., Decker, K. (1993) Regulation of endothelin-1 action on the perfused rat liver. FEBS Lett. 318: 353357.
  • 14
    Rossi, R., Scharrer, E. (1992) Effect of endothelin 1 on plasma glucose and lipid levels in pygmy goats. Zentralbl Veterinarmed A. 39: 558560.
  • 15
    Wilkes, J. J., Hevener, A., Olefsky, J. (2003) Chronic endothelin-1 treatment leads to insulin resistance in vivo. Diabetes 52: 19041909.
  • 16
    Ieda, M., Fukuda, K., Hisaka, Y., et al (2004) Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression. J Clin Invest. 113: 876884.
  • 17
    Liu, J. L., Pliquett, R. U., Brewer, E., Cornish, K. G., Shen, Y. T., Zucker, IH. (2001) Chronic endothelin-1 blockade reduces sympathetic nerve activity in rabbits with heart failure. Am J Physiol Regul Integr Comp Physiol. 280: R1906R1913.
  • 18
    Navegantes, L. C., Sjostrand, M., Gudbjornsdottir, S., Strindberg, L., Elam, M., Lonnroth, P. (2003) Regulation and counterregulation of lipolysis in vivo: different roles of sympathetic activation and insulin. J Clin Endocrinol Metab. 88: 55155520.
  • 19
    Hucking, K., Hamilton-Wessler, M., Ellmerer, M., Bergman, RN. (2003) Burst-like control of lipolysis by the sympathetic nervous system in vivo. J Clin Invest. 111: 257264.
  • 20
    Rodbell, M. (1964) Metabolism of isolated fat cell: I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem. 239: 375380.
  • 21
    Juan, C. C., Chang, C. L., Lai, Y. H., Ho, LT. (2005) Endothelin-1 induces lipolysis in 3T3–L1 adipocytes. Am J Physiol Endocrinol Metab. 288: E1146E1152.
  • 22
    Evans, J. L., Honer, C. M., Womelsdorf, B. E., Kaplan, E. L., Bell, PA. (1995) The effects of wortmannin, a potent inhibitor of phosphatidylinositol 3-kinase, on insulin-stimulated glucose transport, GLUT4 translocation, antilipolysis, and DNA synthesis. Cell Signal 7: 365376.
  • 23
    Holm, C., Osterlund, T., Laurell, H., Contreras, JA. (2000) Molecular mechanisms regulating hormone-sensitive lipase and lipolysis. Annu Rev Nutr. 20: 365393.
  • 24
    Honnor, R. C., Dhillon, G. S., Londos, C. (1985) cAMP-dependent protein kinase and lipolysis in rat adipocytes: II. Definition of steady-state relationship with lipolytic and antilipolytic modulators. J Biol Chem. 260: 1513015138.
  • 25
    Eriksson, H., Ridderstrale, M., Degerman, E., et al (1995) Evidence for the key role of the adipocyte cGMP-inhibited cAMP phosphodiesterase in the antilipolytic action of insulin. Biochim Biophys Acta 1266: 101107.
  • 26
    Degerman, E., Belfrage, P., Newman, A. H., Rice, K. C., Manganiello, VC. (1987) Purification of the putative hormone-sensitive cyclic AMP phosphodiesterase from rat adipose tissue using a derivative of cilostamide as a novel affinity ligand. J Biol Chem. 262: 57975807.
  • 27
    Rahn, T., Ridderstrale, M., Tornqvist, H., et al (1994) Essential role of phosphatidylinositol 3-kinase in insulin-induced activation and phosphorylation of the cGMP-inhibited cAMP phosphodiesterase in rat adipocytes: studies using the selective inhibitor wortmannin. FEBS Lett. 350: 314318.
  • 28
    Wijkander, J., Landstrom, T. R., Manganiello, V., Belfrage, P., Degerman, E. (1998) Insulin-induced phosphorylation and activation of phosphodiesterase 3B in rat adipocytes: possible role for protein kinase B but not mitogen-activated protein kinase or p70 S6 kinase. Endocrinology 139: 219227.
  • 29
    Berne, R. M., Levy, M. N., Koeppen, B. M., Stanton, BA. (2004) Hormones of the pancreatic islets Berne, RM Levy, MN eds. Physiology 766793.5th ed, Mosby St Louis, MO.
  • 30
    Nakamura, J., Okamura, N., Kawakami, Y. (2004) Augmentation of lipolysis in adipocytes from fed rats, but not from starved rats, by inhibition of rolipram-sensitive phosphodiesterase 4. Arch Biochem Biophys 425: 106114.
  • 31
    Enoksson, S., Degerman, E., Hagstrom-Toft, E., Large, V., Arner, P. (1998) Various phosphodiesterase subtypes mediate the in vivo antilipolytic effect of insulin on adipose tissue and skeletal muscle in man. Diabetologia 41: 560568.
  • 32
    Bellamy, T. C., Garthwaite, J. (2001) “cAMP-specific” phosphodiesterase contributes to cGMP degradation in cerebellar cells exposed to nitric oxide. Mol Pharmacol. 59: 5461.
  • 33
    Moro, C., Crampes, F., Sengenes, C., et al (2004) Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans. FASEB J. 18: 908910.
  • 34
    Sengenes, C., Bouloumie, A., Hauner, H., et al (2003) Involvement of a cGMP-dependent pathway in the natriuretic peptide-mediated hormone-sensitive lipase phosphorylation in human adipocytes. J Biol Chem. 278: 4861748626.
  • 35
    Tanahashi, T., Yamaguchi, K., Ishikawa, S., Kusuhara, M., Adachi, I., Abe, O. (1991) Endothelin-1 inhibits adipogenic differentiation of 3T3–L1 preadipocytes. Biochem Biophys Res Commun. 177: 854860.
  • 36
    Ishida, F., Saeki, K., Saeki, T., et al (1992) Suppressive effects of the endothelin receptor (ETA) antagonist BQ-123 on ET-1-induced reduction of lipoprotein lipase activity in 3T3–L1 adipocytes. Biochem Pharmacol. 44: 14311436.
  • 37
    Kershaw, E. E., Flier, JS. (2004) Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 89: 25482556.
  • 38
    Xiong, Y., Tanaka, H., Richardson, J. A., et al (2001) Endothelin-1 stimulates leptin production in adipocytes. J Biol Chem. 276: 2847128477.
  • 39
    Clarke, K. J., Zhong, Q., Schwartz, D. D., Coleman, E. S., Kemppainen, R. J., Judd, RL. (2003) Regulation of adiponectin secretion by endothelin-1. Biochem Biophys Res Commun. 312: 945949.
  • 40
    Zhong, Q., Lin, C. Y., Clarke, K. J., Kemppainen, R. J., Schwartz, D. D., Judd, RL. (2002) Endothelin-1 inhibits resistin secretion in 3T3–L1 adipocytes. Biochem Biophys Res Commun. 296: 383387.
  • 41
    Ferri, C., Bellini, C., Desideri, G., et al (1997) Circulating endothelin-1 levels in obese patients with the metabolic syndrome. Exp Clin Endocrinol Diabetes 105: 3840.
  • 42
    Schneider, J. G., Tilly, N., Hierl, T., et al (2002) Elevated plasma endothelin-1 levels in diabetes mellitus. Am J Hypertens 15: 967972.
  • 43
    Roden, M., Price, T. B., Perseghin, G., et al (1996) Mechanism of free fatty acid-induced insulin resistance in humans. J Clin Invest. 97: 28592865.